In 2023, the re-import of Vitamin B1 to China stood at a competitive volume. Forecasted data indicates a consistent upward trend from 2024 to 2028, starting at 5.54 thousand kilograms in 2024 and reaching 6.53 thousand kilograms by 2028. This marks a steady growth year-on-year, highlighting a positive trajectory in the market.
Key trends to observe in the future include:
- Potential shifts in global supply chain dynamics and their impact on import volumes.
- Changes in Chinese domestic production capabilities affecting re-import needs.
- Regulatory alterations impacting trade flows and pharmaceutical market demands.
